Abstract
Population: 9-16 year-old individuals living in dengue endemic areas
Intervention: 3 doses of CYD-TDV administered 6 months apart
Comparison: Placebo
Outcome: Virologically-confirmed dengue occurring > 12 months of completion of 3 doses
Population: 9-16 year-old individuals living in dengue endemic areas
Intervention: 3 doses of CYD-TDV administered 6 months apart
Comparison: Placebo
Outcome: Virologically-confirmed dengue occurring > 12 months of completion of 3 doses